Literature DB >> 14762866

Complement membrane attack complex and hemodynamic changes during human orthotopic liver transplantation.

Mark C Bellamy1, Jacqui A Gedney, Helen Buglass, Jimmy H C Gooi.   

Abstract

Hemodynamic changes and elevation of intracellular calcium following reperfusion in human liver transplantation occur rapidly and do not match the time course of cytokine expression, therefore, we postulate involvement of other, pre-formed substances, such as complement. We studied 40 adult patients undergoing liver transplantation. Blood was drawn for estimation of C3, C4, C3 degradation product, membrane attack complex, and CH100 levels and elastase (a marker of neutrophil activation) at induction of anesthesia, 5 minutes before reperfusion, 5 minutes and 60 minutes after reperfusion. Cardiac output was measured by thermodilution and systemic vascular resistance was calculated at these same time points. There was a significant rise in C5b-9 membrane attack complex (P =.0012) with a corresponding fall in C3 (P =.0013) and C4 (P =.0002) levels and a rise in C3 degradation product levels (P =.0006). There was no significant change in CH100. These changes very closely followed the hemodynamic changes of a significant fall in systemic vascular resistance index (P =.0024) and increase in cardiac index (P =.0005). Elastase rose from 356 +/- 53 to 557 +/- 40 microg/L (P <.0001). There is complement activation and neutrophil activation at reperfusion in liver transplantation. Dilution alone cannot explain the fall in C3 and C4 levels as there is a corresponding increase in membrane attack complex and C3 degradation product levels with time. As both C3 and C4 are consumed, the classical pathway must be active, though alternative and lectin activated pathways may also be involved. These findings may, at least in part, explain the hemodynamic changes typically seen at reperfusion in liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762866     DOI: 10.1002/lt.20061

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

Review 1.  Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.

Authors:  Antonio Siniscalchi; Lorenzo Gamberini; Cristiana Laici; Tommaso Bardi; Giorgio Ercolani; Laura Lorenzini; Stefano Faenza
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Hyperbaric oxygen therapy and liver transplantation.

Authors:  Vijayaragavan Muralidharan; Chris Christophi
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

3.  Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.

Authors:  Suk-Hee Park; Gaab-Soo Kim
Journal:  Korean J Anesthesiol       Date:  2014-06-26

4.  Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.

Authors:  Jeffrey M Saland; Benjamin L Shneider; Jonathan S Bromberg; Patricia A Shi; Stephen C Ward; Margret S Magid; Corinne Benchimol; Mouin G Seikaly; Sukru H Emre; Elena Bresin; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 8.237

5.  Blood coagulation abnormalities in multibacillary leprosy patients.

Authors:  Débora Santos da Silva; Lisandra Antonia Castro Teixeira; Daniela Gois Beghini; André Teixeira da Silva Ferreira; Márcia de Berredo Moreira Pinho; Patricia Sammarco Rosa; Marli Rambaldi Ribeiro; Monica Di Calafiori Freire; Mariana Andrea Hacker; José Augusto da Costa Nery; Maria Cristina Vidal Pessolani; Ana Maria Freire Tovar; Euzenir Nunes Sarno; Jonas Perales; Fernando Augusto Bozza; Danuza Esquenazi; Robson Queiroz Monteiro; Flavio Alves Lara
Journal:  PLoS Negl Trop Dis       Date:  2018-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.